Neuberger Berman Group
FLNA

Neuberger Berman Group’s Filana Therapeutics FLNA Stock Holding History

Neuberger Berman Group’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-59,528
Closed -$1.34M – 1910
2023
Q4 		$1.34M Sell
59,528
-4,649
-7% -$98.2K ﹤0.01% 1201
2023
Q3 		$1.07M Buy
64,177
+15,949
+33% +$316K ﹤0.01% 1235
2023
Q2 		$1.18M Sell
48,228
-43
-0.1% -$1.04K ﹤0.01% 1198
2023
Q1 		$1.16M Buy
48,271
+154
+0.3% +$4.27K ﹤0.01% 1206
2022
Q4 		$1.42M Buy
48,117
+45
+0.1% +$1.62K ﹤0.01% 1144
2022
Q3 		$2.01M Buy
48,072
+72
+0.2% +$1.94K ﹤0.01% 1077
2022
Q2 		$1.35M Buy
48,000
+5,000
+12% +$126K ﹤0.01% 1215
2022
Q1 		$1.6M Buy
43,000
+5,000
+13% +$212K ﹤0.01% 1238
2021
Q4 		$1.66M Buy
38,000
+3,000
+9% +$157K ﹤0.01% 1239
2021
Q3 		$2.17M Buy
35,000
+13,000
+59% +$1.08M ﹤0.01% 1153
2021
Q2 		$1.88M Buy
22,000
+15,000
+214% +$804K ﹤0.01% 1196
2021
Q1 		$315K Buy
+7,000
New +$275K ﹤0.01% 1597

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Neuberger Berman Group's FLNA Position: Q1 2024 in Review

Neuberger Berman Group sold out of Filana Therapeutics (FLNA) in Q1 2024, closing a stake of 59,528 shares — an estimated $1.34M sold.

Neuberger Berman Group first reported a position in FLNA in Q1 2021 and held it in 12 quarters. The position peaked at $2.17M in Q3 2021. 143 funds tracked by Wall St. Rank hold FLNA as of Q1 2024.

  • Neuberger Berman Group reported no remaining Filana Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Neuberger Berman Group sold 59,528 Filana Therapeutics shares in Q1 2024, an estimated $1.34M.
  • Neuberger Berman Group first reported a position in Filana Therapeutics in Q1 2021 and held it in 12 quarters.
  • Neuberger Berman Group's Filana Therapeutics position peaked at $2.17M in Q3 2021.
  • 143 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2024.

Based on Neuberger Berman Group's 13F filing for Q1 2024, filed 13 May 2024.